会员体验
专利管家（专利管理）
工作空间（专利管理）
风险监控（情报监控）
数据分析（专利分析）
侵权分析（诉讼无效）
联系我们
交流群
官方交流：
QQ群： 891211   
微信请扫码    >>>
现在联系顾问~
下载
著录项
PDF全文
热词
    • 8. 发明授权
      US06613770B1 Quinoline derivatives as NK-2 and NK-3 receptor ligands 失效
    • Quinoline derivatives as NK-2 and NK-3 receptor ligands
    • 喹啉衍生物作为NK-2和NK-3受体配体
    • US06613770B1
    • 2003-09-02
    • US09856385
    • 2001-09-28
    • Carlo Farina , Giuseppe Giardina , Mario Grugni , Guy Marguerite Marie Gerard Nadler , Luca Francesco Raveglia
    • Carlo Farina , Giuseppe Giardina , Mario Grugni , Guy Marguerite Marie Gerard Nadler , Luca Francesco Raveglia
    • A61K314725
    • C07D401/06 , C07D215/52 , C07D401/14
    • A compound, or a solvate or a salt thereof, of formula (I): wherein R is linear or branched alkyl; R1 represents hydrogen or up to four optional substituents selected from the list consisting of: C1-6 alkyl, C1-6 alkenyl, aryl, C1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulphonamido, C1-6 alkoxycarbonyl, trifluoromethyl, acyloxy, phthalimido, amino or mono- and di-C1-6 alkylamino; R2 represents a moiety —(CH2)n—NY1Y2 wherein n is an integer in the range of from 1 to 9, Y1 and Y2 are independently selected from hydrogen; C1-6-alkyl; C1-6 alkyl substituted with hydroxy, C1-6 alkylamino or bis (C1-6 alkyl) amino; C1-6-alkenyl; aryl or aryl-C1-6-alkyl or Y1 and Y2 together with the nitrogen atom to which they are attached represent an optionally substituted N-linked single or fused ring heterocyclic group; R3 is branched or linear C1-6 alkyl, C3-7 cycloalkyl, C4-7 cycloalkylalkyl, optionally substituted aryl, or an optionally substituted single or fused ring aromatic heterocyclic group; and R4 represents hydrogen or alkyl or R4 and R together with the carbon atom to which they are attached form an optionally substituted C3-12 cycloalkyl group; a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds and composition in medicine.
    • 式（I）的化合物或其溶剂化物或其盐：其中R是直链或支链烷基; R1代表氢或最多四个选自下列的任选取代基：C 1-6烷基，C 1-6烯基 芳基，C 1-6烷氧基，羟基，卤素，硝基，氰基，羧基，甲酰胺基，磺酰氨基，C 1-6烷氧基羰基，三氟甲基，酰氧基，苯二甲酰亚氨基，氨基或单-C2和二-C6烷基氨基; R2代表 - （CH2）n-NY1Y2其中n是1至9的整数，Y1和Y2独立地选自氢; C 1-6 - 烷基; 被羟基，C 1-6烷基氨基或双（C 1-6烷基）氨基取代的C 1-6烷基; C 1-6 - 烯基; 芳基或芳基-C 1-6 - 烷基或Y1和Y2与它们所连接的氮原子一起表示任选取代的N-连接的单或稠环杂环基; R 3是支链或直链C 1-6烷基，C 3-7 环烷基，C 4-7环烷基烷基，任选取代的芳基或任选取代的单环或稠环芳族杂环基; R 4表示氢或烷基或R 4，R与它们所连接的碳原子一起形成任选取代的C 3-12环烷基; 制备这种化合物的方法，包含这些化合物的药物组合物以及这些化合物和组合物在医药中的用途。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Espacenet 法律信息 同族专利 专利引用
    • 10. 发明授权
      US06780875B2 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists 失效
    • Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
    • 喹啉-4-甲酰胺衍生物作为NK-3和NK-2受体拮抗剂
    • US06780875B2
    • 2004-08-24
    • US10358938
    • 2003-02-05
    • Carlo Farina , Giuseppe Giardina , Mario Grugni , Marcel Morvan , Guy Marguerite Marie Gérard Nadler , Luca Francesco Raveglia
    • Carlo Farina , Giuseppe Giardina , Mario Grugni , Marcel Morvan , Guy Marguerite Marie Gérard Nadler , Luca Francesco Raveglia
    • A61K314709
    • C07D401/06 , C07D215/52 , C07D401/12 , C07D401/14 , C07D413/10 , C07D417/12 , C07D471/10 , C07D487/04 , C07D487/10 , C07D491/10
    • A compound, or a solvate or a salt thereof, of formula (I): wherein, Ar is an optionally substituted aryl or a C5-7 cycloalkdienyl group, or an optionally substituted C5-7 cycloalkyl group, or an optionally substituted single or fused ring aromatic heterocyclic group; R is hydrogen, linear or branched C1-6 alkyl, C3-7 cycloalkyl, C3-7 cycloalkylalkyl; R1 represents hydrogen or up to three optional substituents selected from the list consisting of: C1-6 alkyl, C1-6 alkenyl, aryl, C1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulphonamido, C1-6 alkoxycarbonyl, trifluoromethyl, acyloxy, amino or mono- and di-C1-6 alkylamino, R2 represents a moiety —(CH2)n—NYY2 wherein n is an integer in the range of from 1 to 9, Y1 and Y2 are independently selected from C1-6-alkyl; C1-6 alkyl substituted with hydroxy, alkoxy, C1-6 alkylamino or bis (C1-6 alkyl) amino; C3-6 cycloalkyl; C4-6 azacycloalkyl; C1-6-alkenyl; aryl or aryl-C1-6-alkyl or Y1 and Y2 together with the nitrogen atom to which they are attached represent an optionally substituted N-linked single or fused ring heterocyclic group; R3 is branched or linear C1-6 alkyl, C3-7 cycloalkyl, C4-7 cycloalkylalkyl, optionally substituted aryl, or an optionally substituted single or fused ring aromatic heterocyclic group; and R4 represents hydrogen or C1-6 alkyl, R5 represents hydrogen or halogen; a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds and composition in medicine.
    • 式（I）的化合物或其溶剂化物或其盐：其中，Ar为任选取代的芳基或C 5-7环二烯基，或任选取代的C 5-7环烷​​基，或任选取代的单或稠合 环芳族杂环基团; R是氢，直链或支链C 1-6烷基，C 3-7环烷基，C 3-7环烷基烷基; R 1代表氢或最多三个选自下列的任选取代基：C 1-6烷基， 6-烯基，芳基，C 1-6烷氧基，羟基，卤素，硝基，氰基，羧基，甲酰氨基，磺酰氨基，C 1-6烷氧基羰基，三氟甲基，酰氧基，氨基或单-C 1-6烷基氨基， （CH 2）n -NYY 2，其中n是1至9的整数，Y 1和Y 2独立地选自C 1-6 - 烷基; 被羟基，烷氧基，C 1-6烷基氨基或双（C 1-6烷基）氨基取代的C 1-6烷基; C3-6环烷基; C4-6氮杂环烷基; C 1-6 - 烯基; 芳基或芳基-C 1-6 - 烷基或Y1和Y2与它们所连接的氮原子一起表示任选取代的N-连接的单或稠环杂环基; R 3是支链或直链C 1-6烷基，C 3-7 环烷基，C 4-7环烷基烷基，任选取代的芳基或任选取代的单环或稠环芳族杂环基; R 4表示氢或C 1-6烷基，R 5表示氢或卤素; 制备这种化合物的方法，包含这些化合物的药物组合物以及这些化合物和组合物在医药中的用途。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Espacenet 法律信息 同族专利 专利引用
每页展示10个专利
每页展示10个专利
每页展示20个专利
每页展示50个专利
每页展示100个专利

IPRDB

最新中国发明专利 最新美国发明专利 技术领域 专利库 专利分类库 国际专利分类库

热门服务

会员版试用 API 数据接口 找代理 知嘟嘟专利交易 排行榜 大学排行榜 专利百科

关于我们

平台介绍 战略合作 网站地图

友情链接

知嘟嘟专利交易 国家知识产权局 中国商标网

联系方式


©2019-2023 上海吉码数字技术有限公司 版权所有，并保留所有权利 沪ICP备20016256号-6 沪公网安备31011702005475号